Loading clinical trials...
Loading clinical trials...
Randomised Double-blinded Split-face Controlled Study to Evaluate the Effectiveness of Eflornithine Hydrochloride Cream Compared to Topical Hydroquinone 2% Cream for the Treatment of Melasma.
Conditions
Interventions
Eflornithine hydrochloride cream
Hydroquinone cream
Locations
1
Singapore
National Skin Centre
Singapore, Singapore
Start Date
June 6, 2023
Primary Completion Date
July 11, 2024
Completion Date
July 11, 2024
Last Updated
May 5, 2025
NCT06516419
NCT07296549
NCT06644157
NCT07345507
NCT05326997
NCT03953209
Lead Sponsor
National Skin Centre
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions